-
CORRECTED: First Comprehensive Heart Failure Center certified outside the U.S.
17 Oct 2025 16:11 GMT
… ’s criteria for Comprehensive Heart Failure Center Certification, cementing the … hospitals provide guideline-directed medical therapies.
“This milestone reflects … rigorous standards for Comprehensive Heart Failure Center Certification, Instituto Nacional …
-
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
17 Oct 2025 22:14 GMT
… 2025.
Next-generation therapy CRD-38 for heart failure funded through to … with pericarditis, myocarditis, and heart failure.
The MAVERIC Program in … inflammatory cardiac disorders including cardiomyopathies, heart failure, and myocarditis, and statements …
-
<![CDATA[Vericiguat Improves HFrEF Regardless of Background Therapy, With Justin Ezekowitz, MD]]>
17 Oct 2025 16:49 GMT
… heart failure with reduced ejection fraction (HFrEF), exhibited excellent background therapy … endpoint of cardiovascular mortality and heart failure (HF)-related hospitalization. … directed medical therapy (GDMT), as well as the Heart Failure Collaboratory …
-
Veterinary Oxygen Therapy Market to Reach USD $1.73 Billion by 2029 at 8.1% CAGR
17 Oct 2025 09:00 GMT
… as improvement in veterinary oxygen therapy technology, advancements in veterinary surgical … The Veterinary Oxygen Therapy Market?
The veterinary oxygen therapy market is … health conditions such as congestive heart failure (CHF), asthma, or laryngeal …
-
Which Heart Failure Patients Should Receive GLP 1 Therapy?
15 Oct 2025 09:36 GMT
… cardiologists shows that patients with heart failure and preserved ejection fraction (HFpEF … ‑loss injections becoming a therapeutic option in heart failure?
Yes. We have seen … likewise enrolled obese patients with heart failure and preserved pump function and …
-
Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: Clinical Advances and Therapeutic Prospects
16 Oct 2025 18:18 GMT
… the evolution of therapies for cardiomyopathies and heart failure, we observe … in broader heart failure populations and define its therapeutic positioning relative … to Omecamtiv Mecarbil and standard heart failure therapies.
Beyond direct myosin activators, …
-
Pulmonary Edema Market to Reach USD 12.04 Bn by 2032, Rising CVD, Advanced Diagnostics & Therapies
16 Oct 2025 11:34 GMT
… pulmonary edema, linked to heart failure, coronary artery disease, and … therapies and clinical trials. Novartis secured FDA approval for Entresto targeting heart failure … with preserved ejection fraction (HFpEF), while Verve Therapeutics …
-
<![CDATA[Collaboration in Heart Failure Treatment]]>
13 Oct 2025 20:43 GMT
… of conditions contributing to heart failure progression. Successful management … conflicting therapeutic adjustments. Some organizations have implemented specialized heart failure … the gold standard for heart failure management, incorporating pharmacists …
About
© 1995-2025